These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 6994086

  • 1. Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population.
    Lacey JH, Crisp AH.
    Postgrad Med J; 1980; 56 Suppl 1():79-85. PubMed ID: 6994086
    [Abstract] [Full Text] [Related]

  • 2. Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study.
    Crisp AH, Lacey JH, Crutchfield M.
    Br J Psychiatry; 1987 Mar; 150():355-8. PubMed ID: 3664105
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Multivitamin and dietary supplements, body weight and appetite: results from a cross-sectional and a randomised double-blind placebo-controlled study.
    Major GC, Doucet E, Jacqmain M, St-Onge M, Bouchard C, Tremblay A.
    Br J Nutr; 2008 May; 99(5):1157-67. PubMed ID: 17977472
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects.
    Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS.
    Eur J Clin Nutr; 2003 Oct; 57(10):1268-74. PubMed ID: 14506488
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa.
    Gross H, Ebert MH, Faden VB, Goldberg SC, Kaye WH, Caine ED, Hawks R, Zinberg N.
    J Clin Psychopharmacol; 1983 Jun; 3(3):165-71. PubMed ID: 6308069
    [No Abstract] [Full Text] [Related]

  • 10. Short-term effect of a protein load on appetite and food intake in diseased mildly undernourished elderly people.
    Irvine P, Mouzet JB, Marteau C, Sallé A, Genaitay M, Favreau AM, Berrut G, Ritz P.
    Clin Nutr; 2004 Oct; 23(5):1146-52. PubMed ID: 15380907
    [Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y facilitates activity-based-anorexia.
    Nergårdh R, Ammar A, Brodin U, Bergström J, Scheurink A, Södersten P.
    Psychoneuroendocrinology; 2007 Jun; 32(5):493-502. PubMed ID: 17467917
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of sucrose, glucose and fructose on peripheral and central appetite signals.
    Lindqvist A, Baelemans A, Erlanson-Albertsson C.
    Regul Pept; 2008 Oct 09; 150(1-3):26-32. PubMed ID: 18627777
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacotherapy of anorexia nervosa and bulimia.
    Herzog DB.
    Pediatr Ann; 1984 Dec 09; 13(12):915, 918-9, 923. PubMed ID: 6395077
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic potential of ghrelin in restricting-type anorexia nervosa.
    Hotta M, Ohwada R, Akamizu T, Shibasaki T, Kangawa K.
    Methods Enzymol; 2012 Dec 09; 514():381-98. PubMed ID: 22975066
    [Abstract] [Full Text] [Related]

  • 19. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
    Mitchell JE, Gosnell BA, Roerig JL, de Zwaan M, Wonderlich SA, Crosby RD, Burgard MA, Wambach BN.
    Obes Res; 2003 May 09; 11(5):599-602. PubMed ID: 12740447
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.